Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02125695 · ClinicalTrials.gov registry record
Pilot Tape Harvesting Study
A clinical trial, sponsored by Biogen.
- Completed
- Registry status
- 37
- Enrollment target
NCT02125695: Completed study, sponsored by Biogen.
NCT02125695 is a clinical trial that has completed, run by Biogen. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02125695 has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
Study Summary
The main objectives of the study are: To determine if RNA recovery from tape harvesting allows for the identification of a disease gene signature (e.g., interferon \[IFN\] signature for lupus) or other biomarkers that may differentiate affected from normal or unaffected skin; To determine if the lupus gene signature is differentially expressed in the epidermis from active discoid lupus erythematosus (DLE) or subacute cutaneous lupus erythematosus (SCLE) lesions when compared with unaffected skin from the same participants and from the skin of healthy volunteers (HVs); To determine if the atopic dermatitis (AD) gene signature is differentially expressed in the epidermis from active AD lesions when compared with unaffected skin from the same participants and from the skin of HVs; and To correlate the levels of transcripts of targeted genes in the skin by tape harvesting with those obtained from the blood.
Primary Outcome
Participants with skin disease include participants affected with cutaneous lupus erythematosus (\[CLE\] i.e., DLE or SCLE), SCLE, AD
Interventions
- PROCEDURE Skin Biopsy
- PROCEDURE Blood Sampling
- PROCEDURE Skin Taping
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-08 |
What the finished NCT02125695 record still lists
NCT02125695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Skin Biopsy is the first listed.
NCT02125695 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02125695 about?
NCT02125695 is a clinical study titled "Pilot Tape Harvesting Study". The main objectives of the study are: To determine if RNA recovery from tape harvesting allows for the identification of a disease gene signature (e.g., interferon \[IFN\] signature for lupus) or other biomarkers that may differentiate affected from normal or unaffected skin; To determine if the lup...
What is the current status of trial NCT02125695?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2014-05. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02125695?
The interventions under investigation include: Skin Biopsy (PROCEDURE), Blood Sampling (PROCEDURE), Skin Taping (PROCEDURE).
Who is sponsoring clinical trial NCT02125695?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia